Setting: Hospital

Encompassing all units and departments within a hospital setting

Ferrari

Italy
|
2022-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus

Raguž

Bosnia and Herzegovina
|
2008-2022
  • Infants (<1 year)
  • Fragile population
  • Hospital
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Palivizumab

Redjoul

France
|
2024-2024
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Vaccination

TwinSeVeRS

France
|
2021-2022
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus

ARF-RSV

France
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • Respiratory syncytial virus
  • Blood sample

SPIRAV

France
|
2025-2025
  • Adults (18-64 years)
  • Pregnant women
  • Hospital
  • Outpatient clinic
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Vaccination
  • Nirsevimab
  • Abrysvo

IRIS

Germany
|
2013-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Respiratory syncytial virus
  • Blood sample
  • Nasopharyngeal swab
  • Nasal lining fluid sample

PAPI Study

Germany
|
2021
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Primary care
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Human metapneumovirus

RESP-VIR

Italy
|
2025-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Non-hospital health centre
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Parainfluenza Virus
  • Metapneumovirus

NIRSE-GAL

Spain
|
2023-2026
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Primary care
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

PRIPASCO

Spain
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • Respiratory syncytial virus
  • Bordetella pertussis
  • Blood sample
  • Nasopharyngeal swab

IMAR

Sweden
|
2018-2022
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Intensive care unit
  • Respiratory syncytial virus